1.888.528.8687
  • Facebook
  • Twitter
  • RSS
  • Facebook
  • Twitter
  • RSS
Relevium Technologies Inc.
  • About Us
    • Our Company
    • Board of Directors & Leadership
  • Our Business
    • OTC Health and Wellness
    • Endo-Medical Cannabis
  • News
    • Press Releases
    • Relevium in the News
  • Investors
    • Financials
    • Corporate Snapshot
  • Contact Us
Select Page

Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense

October 17, 2019

MONTREAL, Oct. 17, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly- owned subsidiary, Biocannabix (“BCX”), has executed an Agreement (the...

Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada

October 9, 2019

MONTREAL, Oct. 09, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that it has registered four hundred (400) Natural Product Numbers (NPNs) with...

Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

September 19, 2019

MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new, publicly-traded company through a spin-out of its pediatric,...

Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters

September 11, 2019

MONTREAL, Sept. 11, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the Company’s annual general and special meeting (the...

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

August 1, 2019

MONTREAL, Aug. 01, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high in monthly sales in the month of July 2019 for its...

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

July 10, 2019

MONTREAL, July 10, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”),...
« Older Entries
Next Entries »
© 2019 Relevium Technologies Inc. | All rights reserved.